Incal bx skn ea sep/addl
CPT 11107 is used when a doctor takes additional skin samples (biopsies) during the same visit after the first one. Each extra biopsy from a separate skin lesion gets billed with this add-on code.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Always verify that primary code 11106 is billed first on the same claim; 11107 will deny if billed without the primary code
Impact: Prevents 100% denial - this is an add-on code that cannot stand alone and will be rejected without proper sequencing
Document the exact number and distinct anatomic locations of each separate lesion biopsied to support multiple units of 11107
Impact: Each properly documented additional lesion generates $67.93 (non-facility) or $29.44 (facility) in Medicare revenue
Non-facility setting yields $38.49 more per additional biopsy than facility setting ($67.93 vs $29.44); consider site of service economics
Impact: For 3 additional lesions (3 units of 11107), non-facility generates $115.47 more revenue than facility setting
Do not bill 11107 with shave biopsy codes (11102-11103) or punch biopsy codes (11104-11105); incisional biopsies are a distinct technique
Impact: Mixing biopsy code families typically results in denial or downcoding, potentially losing $30-70 per incorrectly coded lesion
Link each biopsy to a specific ICD-10 code representing the clinical indication; multiple biopsies may have different diagnosis codes
Impact: Specific diagnosis linkage supports medical necessity and reduces audit risk, particularly when billing 4+ units of 11107
Check individual payer policies for maximum units per day; some MACs and commercial payers flag claims with more than 5-6 total biopsies for review
Impact: Proactive documentation and potential pre-authorization for extensive biopsy sessions prevents payment delays on high-dollar claims ($200+)
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.